SKELTER: unsupervised skeleton action denoising and recognition using transformers

Unsupervised Human Action Recognition (U-HAR) methods currently leverage large-scale datasets of human poses to solve this challenging problem. As most of the approaches are dedicated to reaching the best recognition accuracies, no attention has been put into analyzing the resilience of such methods given perturbed data, a likely occurrence in real in-the-wild testing scenarios. Our first contribution is to systematically validate the decrease in performance of current U-HAR state-of-the-art using perturbed or altered data (e.g., obtained by removing some skeletal joints, rotating the entire pose, and injecting geometrical aberrations). Then, we propose a novel framework based on a transformer encoder–decoder with remarkable de-noising capabilities to counter such perturbations effectively. Moreover, we also present additional losses to have robust representations against rotation variances and provide temporal motion consistency. Our model, SKELTER, shows limited drops in performance when skeleton noise is present compared with previous approaches, favoring its use in challenging in-the-wild settings

Unsupervised Human Action Recognition with Skeletal Graph Laplacian and Self-Supervised Viewpoints Invariance

This paper presents a novel end-to-end method for the problem of skeleton-based unsupervised human action recognition. We propose a new architecture with a convolutional autoencoder that uses graph Laplacian regularization to model the skeletal geometry across the temporal dynamics of actions. Our approach is robust towards viewpoint variations by including a self-supervised gradient reverse layer that ensures generalization across camera views. The proposed method is validated on NTU-60 and NTU-120 large-scale datasets in which it outperforms all prior unsupervised skeleton-based approaches on the cross-subject, cross-view, and cross-setup protocols. Although unsupervised, our learnable representation allows our method even to surpass a few supervised skeleton-based action recognition methods. The code is available in: www.github.com/IIT-PAVIS/UHAR_Skeletal_Laplacia

Un motore di Workflow per applicazioni web

Progettazione e sviluppo di un motore di workflow per processi gestionali informatizzati. Il termine workflow identifica il modello digitale di un processo di business attraverso la sua rappresentazione in forma di grafo orientato. Ogni nodo del grafo identifica un’azione ben definita, declinata in forma di passaggi decisionali, sottoprocessi e/o manipolazione dei dati di contesto, con l’obiettivo di supportare l’iter di un processo in maniera efficiente, misurabile e ripetibile. La definizione di un workflow implica sia aspetti statici che dinamici di un processo e ne modella il comportamento come un automa a stati finiti. Ogni collegamento dell’automa stabilisce un collegamento fra due attività, definendo condizioni di percorrenza formalizzate come funzioni booleane. Tali funzioni sono attivate nel momento in cui un attore o un sotto-processo conclude le attività previste dalla fase attuale e vuole transire alla successiva. Emerge, a questo punto, la necessità di un orchestratore che governi l’andamento del workflow, garantisca il rispetto dei vincoli imposti dal processo sottostante e punti alla “fase attuale” del flusso, permettendo di individuare i percorsi attivabili e le condizioni di percorribilità in funzione del contesto e degli attori

Hypnotizability-related complexity of heart rate variability during long lasting relaxation

Aim of the experiment was to compare heart rate and HRV of healthy subjects with high (Highs) and low (Lows) susceptibility to hypnosis during long-lasting relaxation. HRV indexes extracted in the frequency and time domain as well as related to the complexity of the tachogram (entropy) were analyzed through repeated measures ANOVA. The results indicated a parasympathetic prevalence in Highs all over the session and a sympathetic modulation across the session in both groups reflected in the sd2 dimension of the Poincar? plot and in entropy. The possible role of the Very Low Frequency spectral component in these changes, supported by the different correlations between entropy and frequency/time related indexes of HRV, is suggeste

Role of anti-cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection-associated polyarticular involvement

This study was performed to assess the utility of anti-cyclic citrullinated peptide (anti-CCP) antibodies in distinguishing between patients with rheumatoid arthritis (RA) and patients with polyarticular involvement associated with chronic hepatitis C virus (HCV) infection. Serum anti-CCP antibodies and rheumatoid factor (RF) were evaluated in 30 patients with RA, 8 patients with chronic HCV infection and associated articular involvement and 31 patients with chronic HCV infection without any joint involvement. In addition, we retrospectively analysed sera collected at the time of first visit in 10 patients originally presenting with symmetric polyarthritis and HCV and subsequently developing well-established RA. Anti-CCP antibodies and RF were detected by commercial second-generation anti-CCP2 enzyme-linked immunosorbent assay and immunonephelometry respectively. Anti-CCP antibodies were detected in 23 of 30 (76.6%) patients with RA but not in patients with chronic HCV infection irrespective of the presence of articular involvement. Conversely, RF was detected in 27 of 30 (90%) patients with RA, 3 of 8 (37.5%) patients with HCV-related arthropathy and 3 of 31 (9.7%) patients with HCV infection without joint involvement. Finally, anti-CCP antibodies were retrospectively detected in 6 of 10 (60%) patients with RA and HCV. This indicates that anti-CCP antibodies can be useful in discriminating patients with RA from patients with HCV-associated arthropathy

Epidermal growth factor receptor gene copy number in 101 advanced colorectal cancer patients treated with chemotherapy plus cetuximab

<p>Abstract</p> <p>Background</p> <p>Responsiveness to Cetuximab alone can be mediated by an increase of Epidermal Growth factor Receptor (EGFR) Gene Copy Number (GCN). Aim of this study was to assess the role of EGFR-GCN in advanced colorectal cancer (CRC) patients receiving chemotherapy plus Cetuximab.</p> <p>Methods</p> <p>One hundred and one advanced CRC patients (43 untreated- and 58 pre-treated) were retrospectively studied by fluorescence in situ hybridization (FISH) to assess EGFR-GCN and by immunohistochemistry (IHC) to determine EGFR expression. Sixty-one out of 101 patients were evaluated also for k-ras status by direct sequencing. Clinical end-points were response rate (RR), progression-free survival (PFS) and overall survival (OS).</p> <p>Results</p> <p>Increased EGFR-GCN was found in 60/101 (59%) tumor samples. There was no correlation between intensity of EGFR-IHC and EGFR-GCN (p = 0.43). Patients receiving chemotherapy plus Cetuximab as first line treatment had a RR of 70% (30/43) while it was 18% (10/56) in the group with previous lines of therapy (p < 0.0001). RR was observed in 29/60 (48%) of patients with increased EGFR-GCN and in 6/28 (21%) in those without (p = 0.02). At multivariate analyses, number of chemotherapy lines and increased EGFR-GCN were predictive of response; EGFR-IHC score, increased EGFR-GCN and number of chemotherapy lines were significantly associated with a significant better PFS. Response to therapy was the only prognostic predictive factor for OS. In the 60 patients analyzed for k-ras mutations, number of chemotherapy lines, increased EGFR-GCN and k-ras wild type status predicted a better PFS.</p> <p>Conclusion</p> <p>In metastatic CRC patients treated with chemotherapy plus Cetuximab number of chemotherapy lines and increased EGFR-GCN were significantly associated with a better clinical outcome, independent of k-ras status.</p

Il portale web degli acquisti INFN

L’oggetto di questo lavoro consiste nella descrizione delle applicazioni e dei servizi web progettati per il nuovo portale degli acquisti INFN. Sono descritti aspetti architetturali, metodologici ed organizzativi relativi al sistema nel suo insieme, rimandando a futuri lavori gli approfondimenti sulle singole componenti applicative

Association of asthma with extra-respiratory symptoms in schoolchildren: two cross-sectional studies 6 years apart

Epidemiological information on symptoms affecting extra-respiratory organs and apparatuses in asthmatic children is scarce. The aim of this study therefore was to evaluate, at a population level, if and what extra-respiratory symptoms are associated with asthma. Two questionnaire-based, cross-sectional surveys were carried out on 1,262 students (651 males; mean age 9.57 years, age-range 6-14 years) in 1992 and on 1,210 students (639 males; mean age 9.02 years, age-range 6-14 years) in 1998, from two elementary and two junior high schools in Rome, Italy. Questionnaires included queries about asthma and its risk factors and extra-respiratory symptoms (headache, restlessness, sleep disturbances, urticaria, itching, and abdominal pain). Of responders, 11.9% (279/2,342) had a history of asthma. After adjustment for gender, family history of atopic disease, low birth weight, early respiratory problems, and damp house, asthma was significantly associated with recurrent abdominal pain (odds ratio [OR] 1.90; 95% confidence interval [CI]: 1.04, 3.16), itching (OR 3.15; 95% CI: 1.75, 5.68), and urticaria (OR 2.52; 95% CI: 1.02, 6.20). Asthma was reported by 10.2% (201/1,962) of children unaffected by this triad, by 20.1% (56/279; OR 2.20) with one of the symptoms, and by 31.6% (12/38; OR 4.04) with two or more symptoms. An emerging characteristic of pediatric asthma in our setting appears to be its association with certain extra-respiratory symptoms (abdominal pain, itching, and urticaria). A global, internistic approach to asthmatic children is increasingly required both in the clinical setting and in future epidemiological studies

Exploring Cosmic Origins with CORE: Cosmological Parameters

We forecast the main cosmological parameter constraints achievable with theCORE space mission which is dedicated to mapping the polarisation of the CosmicMicrowave Background (CMB). CORE was recently submitted in response to ESA'sfifth call for medium-sized mission proposals (M5). Here we report the resultsfrom our pre-submission study of the impact of various instrumental options, inparticular the telescope size and sensitivity level, and review the great,transformative potential of the mission as proposed. Specifically, we assessthe impact on a broad range of fundamental parameters of our Universe as afunction of the expected CMB characteristics, with other papers in the seriesfocusing on controlling astrophysical and instrumental residual systematics. Inthis paper, we assume that only a few central CORE frequency channels areusable for our purpose, all others being devoted to the cleaning ofastrophysical contaminants. On the theoretical side, we assume LCDM as ourgeneral framework and quantify the improvement provided by CORE over thecurrent constraints from the Planck 2015 release. We also study the jointsensitivity of CORE and of future Baryon Acoustic Oscillation and Large ScaleStructure experiments like DESI and Euclid. Specific constraints on the physicsof inflation are presented in another paper of the series. In addition to thesix parameters of the base LCDM, which describe the matter content of aspatially flat universe with adiabatic and scalar primordial fluctuations frominflation, we derive the precision achievable on parameters like thosedescribing curvature, neutrino physics, extra light relics, primordial heliumabundance, dark matter annihilation, recombination physics, variation offundamental constants, dark energy, modified gravity, reionization and cosmicbirefringence. (ABRIDGED

Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

Background and objective: Chronic obstructive pulmonary disease (COPD) and heart failure (HF) mutually increase the risk of being present in the same patient, especially if older. Whether or not this coexistence may be associated with a worse prognosis is debated. Therefore, employing data derived from the REPOSI register, we evaluated the clinical features and outcomes in a population of elderly patients admitted to internal medicine wards and having COPD, HF or COPD + HF. Methods: We measured socio-demographic and anthropometric characteristics, severity and prevalence of comorbidities, clinical and laboratory features during hospitalization, mood disorders, functional independence, drug prescriptions and discharge destination. The primary study outcome was the risk of death. Results: We considered 2,343 elderly hospitalized patients (median age 81 years), of whom 1,154 (49%) had COPD, 813 (35%) HF, and 376 (16%) COPD + HF. Patients with COPD + HF had different characteristics than those with COPD or HF, such as a higher prevalence of previous hospitalizations, comorbidities (especially chronic kidney disease), higher respiratory rate at admission and number of prescribed drugs. Patients with COPD + HF (hazard ratio HR 1.74, 95% confidence intervals CI 1.16-2.61) and patients with dementia (HR 1.75, 95% CI 1.06-2.90) had a higher risk of death at one year. The Kaplan-Meier curves showed a higher mortality risk in the group of patients with COPD + HF for all causes (p = 0.010), respiratory causes (p = 0.006), cardiovascular causes (p = 0.046) and respiratory plus cardiovascular causes (p = 0.009). Conclusion: In this real-life cohort of hospitalized elderly patients, the coexistence of COPD and HF significantly worsened prognosis at one year. This finding may help to better define the care needs of this population